Artbio in a $132 million Series B deal co-led by Sofinnova Investments and B Capital, joined by F-Prime, Omega Funds, and Third Rock Ventures.
05 July 2025
05 July 2025
Total investments received (USD): 245M
Round value (USD): 132M
Company: Artbio
Related deals
OrganOx was acquired by Terumo Corporation, a global medical technology company headquartered in Tokyo in a deal valued at approximately £1.5 billion
Secondary
14 July 2025
Draig Therapeutics raised £107m with Access Biotechnology (led), SV Health Investors, ICG, Canaan Partners, SR One, Sanofi Ventures, and Schroders Capital.
Investments
07 June 2025
GlycoEra raised $130m in Series B led by Novo, joined by Catalio Capital, LifeArc Ventures, QIA, Sixty Degree Capital, Agent Capital, MP Healthcare, Sofinnova.
Investments
17 May 2025
CellCentric raised $120m in Series C funding led by RA Capital Management, joined by Forbion, Avego Bioscience Capital, and BrightEdge.
Investments
09 May 2025
Azafaros raised a €132M Series B financing led by Jeito Capital, co-led by Forbion Growth and joined by Seroba, Pictet Group, Schroders and BioGeneration.
Investments
02 May 2025
Belgium
Austria
Germany
Estonia
Finland
Iceland
Latvia
Lithuania
Sweden
Italy
Portugal
Spain